Skip to content

Clinical Features and Outcome of Wilson's Disease With Generalized Epilepsy in Chinese Patients

Clinical Features and Outcome of Wilson's Disease With Generalized Epilepsy in Chinese Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04965571
Enrollment
13
Registered
2021-07-16
Start date
2010-09-01
Completion date
2019-03-01
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilson Disease, Generalized Epilepsy

Keywords

Chinese, clinical features, generalized epilepsy, outcome, Wilson's disease

Brief summary

Generalized epilepsy is rarely reported in patients with Wilson disease (WD) and lacks experience in clinical practice. We aim to provide better experience for the diagnosis and treatment for WD patients with epilepsy in the future.

Detailed description

A retrospective study was performed in 13 Chinese WD patients with generalized epilepsy. Each patient was diagnosed with WD by clinical evaluation and genetic screening. Patients were given small doses of antiepileptic drugs (AEDs), followed by copper-chelation therapy when the seizures stabilized. Clinical manifestations, brain imaging changes, and treatment and outcome after a long-term follow-up were analyzed.

Interventions

Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA)

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Each patient was diagnosed with WD by clinical evaluation and genetic screening and had ever experienced generalized epilepsy

Exclusion criteria

* Not WD & without generalized epilepsy

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with treatment stop seizures attacks12 monthAfter standard treatment, the patients would stop attacks and get improved.

Secondary

MeasureTime frameDescription
Number of participants with treatment have improved brain MRI12 monthAfter standard treatment, the abnormalities of brain MRI would get better in patients.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026